Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Skin Research Center at Shohada-e Tajrish Hospital, Ghods Sq, Shahrdary St., Tehran, Iran
A one-day intense program, connected with 10th Congress of New Articles, Innovations in Dermatology. Notable speakers include Prof. Parviz Toossi and Prof. Fariba Ghalamkarpour, Prof. Jana Hercogova (Czech Republic), Prof. Torello Lotti (Italy), Dr. Andy Goren (USA), Dr. Zoulikha Zarrab (Russia), Prof. Davinder Parsad (India), Prof. Xing Hua Gao (China) and Prof. Robert A. Schwartz (USA.)
- Polypodium leucotomos as an adjunct treatment for vitiligo?
Extracts of the tropical fern Polypodium leucotomos appear to have beneficial properties for the vitiligious skin. Polypodium leucotomos (also classified as Polypodium aureum) a...
- I have vitiligo: will my children have vitiligo, too?
Children born to parents who both have the disorder are more likely to develop vitiligo. However, most children will not get vitiligo even if one parent has it. In children with...
- Shall I take vitamin D for my vitiligo?
In Brief Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be id...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.